TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,581,749 | -66.4% | 189,206 | -0.1% | 0.00% | -60.0% |
| Q2 2023 | $4,706,186 | +174332.4% | 189,460 | +5.6% | 0.01% | +66.7% |
| Q1 2023 | $2,698 | +33.1% | 179,420 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $2,027 | -99.8% | 171,303 | +5.4% | 0.00% | +200.0% |
| Q3 2022 | $962,000 | +49.4% | 162,531 | +7.3% | 0.00% | 0.0% |
| Q2 2022 | $644,000 | -48.7% | 151,487 | +14.7% | 0.00% | -50.0% |
| Q1 2022 | $1,256,000 | -49.7% | 132,038 | +0.4% | 0.00% | -33.3% |
| Q4 2021 | $2,498,000 | -43.5% | 131,485 | -1.1% | 0.00% | -50.0% |
| Q3 2021 | $4,424,000 | -12.8% | 132,945 | +1.7% | 0.01% | -14.3% |
| Q2 2021 | $5,071,000 | -27.0% | 130,723 | -9.3% | 0.01% | -22.2% |
| Q1 2021 | $6,944,000 | -9.6% | 144,062 | -2.5% | 0.01% | -18.2% |
| Q4 2020 | $7,685,000 | +119.0% | 147,741 | +12.7% | 0.01% | +120.0% |
| Q3 2020 | $3,509,000 | +21.4% | 131,120 | -11.6% | 0.01% | 0.0% |
| Q2 2020 | $2,890,000 | +148.1% | 148,350 | +25.3% | 0.01% | +150.0% |
| Q1 2020 | $1,165,000 | +3.3% | 118,443 | +16.6% | 0.00% | 0.0% |
| Q4 2019 | $1,128,000 | +110.1% | 101,624 | +6.2% | 0.00% | +100.0% |
| Q3 2019 | $537,000 | -33.8% | 95,679 | +2.1% | 0.00% | -50.0% |
| Q2 2019 | $811,000 | +29.8% | 93,703 | +20.6% | 0.00% | +100.0% |
| Q1 2019 | $625,000 | +93.5% | 77,713 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $323,000 | +11.0% | 78,898 | +51.7% | 0.00% | 0.0% |
| Q3 2018 | $291,000 | -59.5% | 52,018 | -4.7% | 0.00% | 0.0% |
| Q2 2018 | $718,000 | +9.6% | 54,587 | +18.3% | 0.00% | 0.0% |
| Q1 2018 | $655,000 | +79.0% | 46,152 | +3.3% | 0.00% | 0.0% |
| Q4 2017 | $366,000 | -42.1% | 44,672 | -16.2% | 0.00% | 0.0% |
| Q3 2017 | $632,000 | +19.5% | 53,292 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $529,000 | +8.2% | 52,602 | +25.2% | 0.00% | 0.0% |
| Q1 2017 | $489,000 | +158.7% | 42,017 | +3.6% | 0.00% | – |
| Q4 2016 | $189,000 | -35.3% | 40,549 | +7.5% | 0.00% | -100.0% |
| Q3 2016 | $292,000 | +28.1% | 37,737 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $228,000 | -22.2% | 37,547 | +9.0% | 0.00% | 0.0% |
| Q1 2016 | $293,000 | -28.5% | 34,440 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $410,000 | +26.9% | 34,400 | +7.5% | 0.00% | 0.0% |
| Q3 2015 | $323,000 | -40.1% | 32,005 | -1.5% | 0.00% | -50.0% |
| Q2 2015 | $539,000 | +30.5% | 32,494 | +21.9% | 0.00% | +100.0% |
| Q1 2015 | $413,000 | +27.5% | 26,654 | +30.3% | 0.00% | 0.0% |
| Q4 2014 | $324,000 | +60.4% | 20,459 | +8.2% | 0.00% | 0.0% |
| Q3 2014 | $202,000 | +14.8% | 18,914 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $176,000 | +141.1% | 18,714 | +76.1% | 0.00% | – |
| Q1 2014 | $73,000 | +65.9% | 10,626 | -5.5% | 0.00% | – |
| Q4 2013 | $44,000 | -25.4% | 11,246 | -2.6% | 0.00% | – |
| Q3 2013 | $59,000 | -16.9% | 11,546 | +3.4% | 0.00% | – |
| Q2 2013 | $71,000 | – | 11,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |